Mr. Cormack served as OncoGenex Pharmaceuticals Inc.’s President, Chief Executive Officer and a director from August 2008 until the consummation of the merger in August 2017. He also co-founded OncoGenex Technologies Inc., currently known as Achieve Life Sciences Technologies Inc., which is Achieve’s wholly owned subsidiary, and was its President from May 2000 and its Chief Executive Officer from February 2002 until the merger in August, 2017, and has been a member of its Board of Directors since May 2000. Mr. Cormack currently serves on the Board of Directors of The Vancouver Prostate Centre at Vancouver General Hospital and The Prostate Centre’s Translation Research Initiative for Accelerated Discovery and Development. Mr. Cormack served as interim President, Chief Executive Officer and Chairman of the Board of Directors of Salpep Biotechnology Inc., an asthma and inflammation biotechnology company, from 2000 to 2001 and on the Board of Directors of Aurinia Pharmaceuticals from 2012 to 2014. From 1998 to 2001, Mr. Cormack served as Vice President of Milestone Medica Corporation, a seed venture capital firm investing in life sciences opportunities. Mr. Cormack holds a B.S. degree from the University of Alberta.